Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review

Surg Neurol. 1998 Feb;49(2):189-95; discussion 196. doi: 10.1016/s0090-3019(97)00218-8.


Background: We review the role of peptide growth factors in angiogenesis and progression of low grade glial tumors to higher grade glioblastoma multiforme (GBM).

Methods: Vascular pathology is a key feature of glioblastoma multiforme characterized by hypervascularity, vascular permeability, and hypercoagulability.

Results: Vascular endothelial growth factor (VEGF) can mediate all of these effects, but by itself does not promote malignant growth. Epidermal growth factor (EGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and transforming growth factor beta (TGF-beta) are implicated in the angiogenesis of a number of tumors including those of glial origin.

Conclusions: These growth factors are suggested to play a role in autocrine and/or paracrine mediated tumorogenesis of astrocytic tumors. VEGF secretion might be the product of induction by physiologic concentrations of other growth factors with VEGF being the common pathway of neovascularization and progression to GBM.

Publication types

  • Review

MeSH terms

  • Animals
  • Disease Progression
  • Endothelial Growth Factors / metabolism
  • Epidermal Growth Factor / metabolism
  • Fibroblast Growth Factors / metabolism
  • Glioma / blood supply*
  • Glioma / metabolism*
  • Growth Substances / metabolism*
  • Humans
  • Lymphokines / metabolism
  • Neovascularization, Pathologic / metabolism*
  • Platelet-Derived Growth Factor / metabolism
  • Transforming Growth Factor beta / metabolism
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors


  • Endothelial Growth Factors
  • Growth Substances
  • Lymphokines
  • Platelet-Derived Growth Factor
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factors
  • Epidermal Growth Factor